BARCELONA, Aug 30 (Reuters) - Patients at risk of stroke due to an irregular heartbeat should soon have a viable alternative to 50-year-old warfarin, after a new pill from Boehringer Ingelheim beat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results